TickerFacts.

ANI Pharmaceuticals Inc (ANIP): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Older than the company's other figures. The latest Gross Profit is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$121.32M
Year ended 2020-12-31
+7.4%
3-year compound annual growth
+13.8%
5-year compound annual growth
$143.39M2012-12-31: $11.20M2013-12-31: $20.11M2014-12-31: $44.50M2015-12-31: $63.63M2016-12-31: $79.84M2017-12-31: $97.81M2018-12-31: $128.55M2019-12-31: $143.39M2020-12-31: $121.32M$121.32M
2012-12-31 Gross Profit (USD) 2020-12-31
Period endedGross ProfitChange YoYSource filing
2020-12-31$121.32M-15.4%2023-03-09, From 2020-01-01
2019-12-31$143.39M+11.5%2022-03-15, From 2019-01-01
2018-12-31$128.55M+31.4%2021-03-11, From 2018-01-01
2017-12-31$97.81M+22.5%2020-02-27, From 2017-01-01
2016-12-31$79.84M+25.5%2019-02-27, From 2016-01-01
2015-12-31$63.63M+43.0%2018-02-27, From 2015-01-01
2014-12-31$44.50M+121.3%2017-03-02, From 2014-01-01
2013-12-31$20.11M+79.5%2016-02-23, From 2013-01-01
2012-12-31$11.20Mn/a2014-02-28, From 2012-01-01